Responses
Other responses
Jump to comment:
- Published on: 18 December 2024
- Published on: 17 November 2024
- Published on: 18 December 2024My Outdated Fondness for Neurological Eponyms
I cannot recall having enjoyed reading a neurology paper quite as much as I enjoyed reading Jason Warren's eloquent exposition on the pros and cons of eponyms in neurology. I was moved to read many of the references cited including Stigler's 1980 paper on his "law of eponymy" that undermines the entire notion of eponymous diseases.
But despite my rational understanding that Frontotemporal Dementia has traveled a great distance from Arnold Pick to 3R-tauopathies; and that Julius Hallervorden and Hugo Spatz, who used murdered victims of the Nazis in their experiments, deserved to have their names stripped from their eponymous disease renamed as Pantothenate Kinase Associated Neurodegeneration (PKAN), I still appreciate most neurological eponyms. I appreciate them for a reason that Warren did not list. Throughout my career it has been curiosity about the origin of neurological eponyms that has led me to learn from and be inspired by the work of the many brilliant neurologists, psychiatrists, neuropathologists and neuropsychologists whose names became associated with these syndromes or observations, regardless of whether they were truly the first to describe them. Often it is the stories of our predecessors through which we inspire our students. I will certainly call a 3R-tauopathy a 3R-tauopathy in teaching my students but I might also digress and tell a brief tale of Arnold Pick of Prague, noting that he did not actually describe the intracell...
Show MoreConflict of Interest:
None declared. - Published on: 17 November 2024On first looking into Warren’s eponyms.
It is such a pleasure to read Prof Warren’s paper, “Neurological Eponyms? Take Your Pick.” In a journal renowned for offering neurologists both scholarly entertainment and useful data, his contribution is an exemplar.
Prof Warren’s eloquent account, which modestly acknowledges earlier forays into the debate “Eponyms good or bad?”, presents a pastiche, historiography and statistical overview of a neurological subset, and proposes a definition of the ideal eponym, which, I suggest, might henceforth be known as ‘The Warren criteria.’
The table of more than 170 eponyms (I did not tally them myself) sets a precedent as the largest in our journal’s history. I shall send it to my amanuensis to assist with the typography of dictation – a process Prof Warren highlights as hazardous for their correct use.
The content promises many rabbit holes to tempt ventures in idle moments. As a starter, I could not resist looking up Brueghel syndrome, and his painting of a yawning older man, eyes closed. Unsure of the distinction from Meige’s syndrome, which also fails the Warren criteria as unhelpful, the literature soon reveals splitters advocating both eponyms be preserved.
What of Williams Hurst’s acute haemorrhagic encephalomyelitis and a second New Zealander for this roll of honour, William Alexander - whose leukodystrophy with Rosenthal fibres (yet another eponym) bears his name? No doubt others will lament missing individuals, as the author warns.
U...
Show MoreConflict of Interest:
None declared.